See how Ergomed’s Phase III Clinical Trial for Locally Advanced Squamous Cell Head & Neck Carcinoma (SCCHN) tackled one of the largest head and neck cancer studies globally.
With 928 patients across 120+ sites in North America, Europe, and Asia, this Rescue study faced challenges in enrollment, complex site coordination, and integrating diverse standards of care.
Discover how Ergomed’s Site Management and Study Physician Support services expanded site reach, enhanced recruitment, and fostered multidisciplinary collaboration across departments. With a 560% patient enrollment increase and significant clinical outcomes, download the full case study to learn how Ergomed drives success in global oncology research.
